Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients With mCRC

ABSTRACT: This study is a phase II study to evaluate the efficacy, safety and tolerability of HLX26 and HLX10 in the treatment of patients with metastatic colorectal carcinoma that had received 3 prior therapies.

DISEASE(S): Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2751724 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR